Human chorionic gonadotropin as a model for a fetal antigen

Area of Science:

• Immunology
• Oncology
• Endocrinology

Background:

• Human chorionic gonadotropin (hCG) possesses significant biological functions and clinical utility as a hormone.
• Its immunological properties have led to widespread applications, including home pregnancy tests.

Purpose of the Study:

• To explore the diverse applications of human chorionic gonadotropin (hCG) as an antigen.
• To evaluate hCG's potential as an ideal tumor marker for choriocarcinoma.
• To investigate hCG as a target for diagnostic and therapeutic strategies in oncology and fertility control.

Main Methods:

• Review of existing literature on hCG's biological functions and antigen properties.
• Analysis of hCG's role in pregnancy tests and tumor marker applications.
• Examination of studies investigating hCG as a target for radioimmunolocalization and antibody therapy.

Main Results:

• hCG serves as a valuable tumor marker for choriocarcinoma, aiding in diagnosis, prognosis, and monitoring.
• Radioimmunolocalization using 131I-labelled anti-hCG antibodies has shown utility in some patients.
• The efficacy of hCG as a target for antibody therapy depends on its function as a cell membrane antigen.

Conclusions:

• Human chorionic gonadotropin (hCG) is a multifaceted molecule with significant applications beyond its hormonal role.
• Its utility as a tumor marker and potential as a therapeutic target underscore its importance in reproductive health and oncology.
• Further research into hCG's cell membrane antigen properties is crucial for advancing antibody-based therapies.